Litigation Updates:

  • ViroPharma Inc. v. Hamburg
    WLF recently filed a brief in the U.S. District Court for the District of Columbia, urging it not to dismiss a challenge to an FDA rule that makes it easier for generic drug manufacturers to demonstrate that their products are bioequivalent to a brand-name drug already on the market…
  • Wal-Mart Stores, Inc. v. Dukes
    WLF recently filed a brief in the U.S. Supreme Court, urging it to overturn a lower-court decision that certified a massive class action against retailer Wal-Mart. The suit was filed by six female Wal-Mart employees who claim that they were denied equal pay and opportunities for promotion. But the trial court certified them as representatives of a class of 1.6 million current and former female employees. WLF argued that the plaintiffs failed to demonstrate that the claims of class members share common issues of fact and law – a prerequisite for certification of a class action…

From The Legal Pulse: